Lixte Biotechnology Holdings, Inc.
LIXT
$5.16
$0.122.38%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.11M | 2.89M | 887.20K | 1.38M | 1.04M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 71.50K | 91.30K | 102.50K | 129.50K | 106.60K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 2.45M | -- | -- | -- |
| Total Current Assets | 5.18M | 5.43M | 989.80K | 1.51M | 1.15M |
|
|
|||||
| Total Current Assets | 5.18M | 5.43M | 989.80K | 1.51M | 1.15M |
| Net Property, Plant & Equipment | 7.56M | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | 198.80K | -- | -- |
| Total Assets | 12.73M | 5.43M | 1.19M | 1.51M | 1.15M |
|
|
|||||
| Total Accounts Payable | 310.50K | 123.90K | 82.10K | 112.50K | 55.70K |
| Total Accrued Expenses | 126.00K | 112.00K | 10.00K | -- | 27.50K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 595.40K | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 301.20K | 285.50K | 445.00K | 242.60K | 235.10K |
| Total Other Current Liabilities | 301.20K | 285.50K | 445.00K | 242.60K | 235.10K |
| Total Current Liabilities | 1.33M | 521.40K | 537.10K | 355.10K | 318.30K |
|
|
|||||
| Total Current Liabilities | 1.33M | 521.40K | 537.10K | 355.10K | 318.30K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 439.00K | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.77M | 521.40K | 537.10K | 355.10K | 318.30K |
|
|
|||||
| Common Stock & APIC | 66.01M | 57.89M | 54.20M | 50.44M | 49.39M |
| Retained Earnings | -58.08M | -55.53M | -53.55M | -52.78M | -52.07M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 7.93M | 2.36M | 651.50K | -2.34M | -2.67M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 1.73M | 2.55M | -- | 3.50M | 3.50M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 1.73M | 2.55M | -- | 3.50M | 3.50M |
|
|
|||||
| Total Common Equity | 7.93M | 2.36M | 651.50K | -2.34M | -2.67M |
| Total Preferred Equity | 1.73M | 2.55M | -- | 3.50M | 3.50M |
| Total Minority Interest | 1.30M | -- | -- | -- | -- |
| Total Equity | 10.96M | 4.91M | 651.50K | 1.16M | 827.20K |
|
|
|||||